Abstract | PURPOSE: PATIENTS AND METHODS: A total of 915 HCC patients with C-P class A were investigated. We assessed the prognosis using FIB-4 index, and factors associated with survival rates were analyzed in these patients. RESULTS: When patients were categorized according to FIB-4 index as <2.0 (n = 93), ≥ 2.0 and <4.0 (n = 311), and ≥ 4.0 (n = 511), survival rates at 5 years were 70.5% [95% confidence interval (CI) 59.0-79.9], 56.4% (95% CI 50.1-62.5), and 47.1% (95% CI 42.2-52.1), respectively. Patients with FIB-4 index <2.0 had a higher survival rate than the other groups (≥ 4.0 vs ≥ 2.0 and <4.0, p = 0.010; ≥ 2.0 and <4.0 vs <2.0, p = 0.028). We were able to predict prognosis in patients with C-P score 5 by FIB-4 index, but survival rate did not significantly differ in patients with C-P score 6. Multivariate analysis identified C-P score, FIB-4 index [≥ 2.0 and <4.0; hazard ratios (HRs) 1.638 (95% CI 1.084-2.474); p = 0.019/≥ 4.0; HR 1.828 (95% CI 1.217-2.744); p = 0.004], Lens culinaris agglutinin-reactive α- fetoprotein, tumor size, number, vascular invasion, antiviral therapy, and hepatectomy as independent predictive factors for survival. CONCLUSIONS: The FIB-4 index is useful for assessing prognosis in HCC patients with C-P class A, especially those with C-P score 5.
|
Authors | Takanori Ito, Takashi Kumada, Hidenori Toyoda, Toshifumi Tada |
Journal | Journal of cancer research and clinical oncology
(J Cancer Res Clin Oncol)
Vol. 141
Issue 7
Pg. 1311-9
(Jul 2015)
ISSN: 1432-1335 [Electronic] Germany |
PMID | 25648362
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- Biomarkers
- Aspartate Aminotransferases
- Alanine Transaminase
|
Topics |
- Age Factors
- Aged
- Alanine Transaminase
(metabolism)
- Aspartate Aminotransferases
(metabolism)
- Biomarkers
(analysis)
- Carcinoma, Hepatocellular
(blood, diagnosis, pathology, physiopathology)
- Female
- Health Status Indicators
- Humans
- Liver
(metabolism, pathology, physiopathology)
- Liver Cirrhosis
(complications, pathology)
- Liver Function Tests
(methods)
- Liver Neoplasms
(blood, diagnosis, pathology, physiopathology)
- Male
- Middle Aged
- Platelet Count
- Prognosis
|